Liposuction for lipedema: what the research shows — from 12-year follow-up to LIPLEG in The Lancet

Only a few years ago, liposuction for lipedema was often called “a cosmetic procedure without evidence”. In 2026 that changed: the first large randomised trial was published, and Germany added the operation to statutory health insurance for all stages. Here is exactly what the research shows — without exaggeration and with all the caveats.

Why evidence was lacking for so long

Until 2026, the effectiveness of liposuction for lipedema was supported mainly by observational studies, in which surgeons described patients’ condition before and after surgery. A 2020 review in Deutsches Ärzteblatt noted that in these studies liposuction relieved symptoms considerably, with only rare complications. But overall the evidence on lipedema treatment was weak at the time, and higher-quality studies were needed for insurance decisions [9].

The main limitation of observational studies is the lack of a comparison group. Without one, it is hard to say how much of the improvement is due to the surgery itself rather than other factors. The LIPLEG trial answered this question.

LIPLEG: how the trial was designed

LIPLEG is a multicentre randomised controlled trial funded by Germany’s Federal Joint Committee (G-BA) [1]. Its key features:

• 11 centres in Germany; 1,973 patients were screened in 2021–2022;
• 410 women with stage I, II or III lipedema of the legs and leg pain of at least 4 out of 10;
• before randomisation, all received conservative therapy for up to 7 months;
• patients were then randomly assigned 2:1: 278 to liposuction and 132 to continued conservative therapy;
• to keep the assessor unaware of group allocation, patches were applied to all patients’ legs before each assessment;
• the primary endpoint was a reduction in leg pain of at least 2 points at 12 months; missing assessments were counted as failures.

According to the Lipedema Foundation, patients weighing over 120 kg and those with significant arm involvement were not included [2].

LIPLEG results

The difference was large and statistically convincing, with an odds ratio of 26.2 [1]. Quality of life also improved more in the liposuction group. According to the Lipedema Foundation, the proportion of patients with a meaningful reduction in pain was similar across all three stages [2]. However, some measures of mental health and social functioning improved less and did not reach statistical significance in all subgroups [2].

Surgery always carries risk, and the trial reports this side honestly:

Reported complications included surgical site infections, drops in blood count and fluid collections under the skin (seroma). According to the Lipedema Foundation, most adverse events were mild or moderate, and none were unexpected or life-threatening [2]. The authors draw a balanced conclusion: liposuction was superior to conservative therapy in reducing pain and improving quality of life, but was associated with a higher rate of serious adverse events [1].

Limitations to bear in mind:

• patients knew which treatment they had received, and pain is a subjective measure;
• only 12-month results have been published; follow-up to 36 months is ongoing [1];
• the G-BA is still awaiting results from the second, non-randomised period (months 13–24), including on the need for repeat operations [4].

What 12 years of follow-up show

Long-term follow-up studies by German researchers answer the question “does it last?”:

• 85 patients at 4 and 8 years after liposuction: improvements in spontaneous pain, sensitivity to pressure, swelling, bruising and restricted movement were maintained, as were improvements in self-rated appearance and quality of life. The need for conservative treatment (decongestive therapy, compression garments) remained lower than before surgery [5].
• 60 patients at 12 years: the improvements were maintained across all these measures. Symptoms increased slightly between years 4 and 8, but not between years 8 and 12 [6].

The weight data are interesting: over 12 years, 55% of patients lost an average of 6.2 kg, while 43.3% gained an average of 7.9 kg [6]. Weight management after surgery therefore remains important.

What the meta-analyses say

A meta-analysis combines the results of several studies. Two were published in 2026.

The first pooled 6 studies with 429 patients whose lipedema had not responded to conservative therapy, with follow-up of 6 to 44 months [7]:

The second meta-analysis covered 10 studies and 901 patients [8]. Pain fell substantially both in the first 6 months and later, and 87.7% of patients reported less pain. Both reviews share a limitation: they rely mainly on observational data. That is why LIPLEG matters so much — it confirmed these findings in a randomised comparison.

Germany: liposuction covered by insurance at all stages

On 17 July 2025, the G-BA decided that liposuction for lipedema can be covered by statutory health insurance regardless of stage [3]. Previously, the operation was covered only in stage III. The decision was based on the first LIPLEG results. The conditions are:

• at least 6 months of continuous conservative therapy (compression and exercise) without sufficient improvement;
• if lipedema occurs with a certain degree of obesity, the obesity is treated first;
• qualification requirements for the doctors who diagnose and operate, and for surgical planning and follow-up.

Who the operation is for

The 2026 international consensus sets out several principles [10]:

• lymph-sparing liposuction should be considered when it can improve lipedema symptoms;
• if lipedema occurs together with obesity and metabolic disease, these are treated first;
• surgery should be performed by specialists with extensive knowledge of lipedema, including conservative treatment, as part of an integrated approach.

So liposuction is neither the first nor the only step, but a stage of treatment for patients whose conservative therapy has not brought enough relief. The decision is made together with the doctor after an examination, a risk assessment and a discussion of realistic expectations.

How we apply this evidence

Our clinic in Kyiv performs lymph-sparing liposuction for lipedema. Before surgery, patients have a consultation with ultrasound and conservative preparation, and afterwards they recover under the care of the same team. We describe how to prepare and what to expect after surgery in “Recovery after lipedema liposuction”.

If you are not sure whether you have lipedema, start with our screening questionnaire. Every treatment result is individual, and at the consultation the doctor will tell you honestly what you can expect in your case.